Overview
First Time in Man Trial for Friulimicin B
Status:
Terminated
Terminated
Trial end date:
2007-09-01
2007-09-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to study the safety of single doses and multiple doses of Friulimicin B in healthy volunteers. The level of Friulimicin B will be measured in the subjects blood and urine. One part of the study will assess if Friulimicin B in the plasma of subjects has activity against bacteria.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
MerLion Pharmaceuticals GmbH
Criteria
Inclusion Criteria:- Male or female healthy subjects
- 18-55 years of age
- In good health
Exclusion Criteria:
- Abnormal physical findings of clinical significance at the Screening examination or
baseline which would interfere with the objectives of the study.